Journal of Antimicrobial Chemotherapy (2001) 48, 225-229
© 2001 The British Society for Antimicrobial Chemotherapy
High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults
a Servicio de Microbiología, Hospital Donostia and b Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad del País Vasco, San Sebastián, Spain
The presence of erythromycin-resistant (ErR) commensal streptococci in the throat of 110 healthy subjects and 87 patients with pharyngitis was investigated. The resistance determinants were studied by PCR using the primers for mef and erm genes, followed by hybridization and sequencing analysis. Overall, 94.4% of the subjects carried one or more ErR strains in their pharynx. A total of 253 ErR strains was studied: 127 (50.2%) showed constitutive or inducible resistance to clindamycin (MLSB phenotype) and 126 (49.8%) were susceptible to clindamycin (M phenotype). In 50 subjects (25.4%) both phenotypes were detected. The ermB gene was predominant among the MLSB phenotype strains (97.6%). The mefA (mefA/mefE) gene was detected in 100% of the strains with the M phenotype. One Streptococcus oralis strain bearing the MLSB phenotype carried both mefA and ermB genes. The mefA gene from clinical isolates of Streptococcus mitis and S. oralis was transferred by conjugation to an erythromycin-susceptible Streptococcus pneumoniae strain.
* Correspondence address. Servicio de Microbiología, Hospital Donostia, Paseo Dr Beguiristain s/n, 20014 San Sebastián (Gipuzkoa), Spain. Tel: +34-943-00-70-46; Fax: +34-943-00-70-63; E-mail: labmikro{at}terra.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. V. Hawkyard and R. J. Koerner The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sangvik, P. Littauer, G. S. Simonsen, A. Sundsfjord, and K. H. Dahl mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway J. Antimicrob. Chemother., November 1, 2005; 56(5): 841 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. W. Klaassen and J. W. Mouton Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E) Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278. [Full Text] [PDF]
|
|
|
|
|
|
I. Rodriguez-Avial, C. Rodriguez-Avial, E. Culebras, and J. J. Picazo In Vitro Activity of Telithromycin against Viridans Group Streptococci and Streptococcus bovis Isolated from Blood: Antimicrobial Susceptibility Patterns in Different Groups of Species Antimicrob. Agents Chemother., February 1, 2005; 49(2): 820 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ardanuy, F. Tubau, J. Linares, M. A. Dominguez, R. Pallares, R. Martin, and The Spanish Pneumococcal Infection Study Network Distribution of Subclasses mefA and mefE of the mefA Gene among Clinical Isolates of Macrolide-Resistant (M-Phenotype) Streptococcus pneumoniae, Viridans Group Streptococci, and Streptococcus pyogenes Antimicrob. Agents Chemother., February 1, 2005; 49(2): 827 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Achour, O. Guenni, B. Malbruny, A. Canu, R. Leclercq, and A. Ben Hassen Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients J. Antimicrob. Chemother., July 1, 2004; 54(1): 117 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malhotra-Kumar, C. Lammens, A. Martel, C. Mallentjer, S. Chapelle, J. Verhoeven, M. Wijdooghe, F. Haesebrouck, and H. Goossens Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium J. Antimicrob. Chemother., February 1, 2004; 53(2): 271 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Phillips, M. Casewell, T. Cox, B. De Groot, C. Friis, R. Jones, C. Nightingale, R. Preston, and J. Waddell Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data J. Antimicrob. Chemother., January 1, 2004; 53(1): 28 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Seppala, M. Haanpera, M. Al-Juhaish, H. Jarvinen, J. Jalava, and P. Huovinen Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora J. Antimicrob. Chemother., October 1, 2003; 52(4): 636 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Alos, B. Aracil, J. Oteo, J. L. Gomez-Garces, and the Spanish Group for the Study of Infection in th Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain J. Antimicrob. Chemother., February 1, 2003; 51(2): 333 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stadler and M. Teuber The Macrolide Efflux Genetic Assembly of Streptococcus pneumoniae Is Present in Erythromycin-Resistant Streptococcus salivarius Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3690 - 3691. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Huovinen Macrolide-Resistant Group A Streptococcus -- Now in the United States N. Engl. J. Med., April 18, 2002; 346(16): 1243 - 1245. [Full Text] [PDF]
|
|